The P1PK blood group system: revisited and resolved.


Journal

Immunohematology
ISSN: 0894-203X
Titre abrégé: Immunohematology
Pays: United States
ID NLM: 8806387

Informations de publication

Date de publication:
Sep 2020
Historique:
entrez: 28 10 2020
pubmed: 29 10 2020
medline: 8 1 2021
Statut: ppublish

Résumé

This update on the P1PK blood group system (Hellberg Å, Westman JS, Thuresson B, Olsson ML. P1PK: the blood group system that changed its name and expanded. Immunohematology 2013;29:25-33) provides recent findings concerning the P1PK blood group system that have both challenged and confirmed old theories. The glycosphingolipids can no longer be considered the sole carriers of the antigens in this system because the P1 antigen has been detected on human red blood cell glycoproteins. New indications suggest that P1Pk synthase activity truly depends on the DXD motif, and the genetic background and molecular mechanism behind the common P1 and P2 phenotypes were found to depend on transcriptional regulation. Transcription factors bind the P1 allele selectively to a motif around rs5751348 in a regulatory region of A4GALT, which enhances transcription of the gene. Nonetheless, unexplained differences in antigen expression between individuals remain.

Identifiants

pubmed: 33112634

Substances chimiques

Blood Group Antigens 0
Galactosyltransferases EC 2.4.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

99-103

Auteurs

Linn Stenfelt (L)

Researcher, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.

Åsa Hellberg (Å)

Technical Director of the Nordic Reference Laboratory for Genomic Blood Group Typing, Department of Clinical Immunology and Transfusion Medicine, Office of Medical Services, Region Skåne, Sweden.

Julia S Westman (JS)

Postdoctoral Researcher, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden; currently at Sanford Burnham Prebys Medical Discovery Institute, Center for Nanomedicine, University of California Santa Barbara.

Martin L Olsson (ML)

Medical Director of the Nordic Reference Laboratory for Genomic Blood Group Typing and Senior Consultant at the Department of Clinical Immunology and Transfusion Medicine, Office of Medical Services, Region Skåne; Professor of Transfusion Medicine at the Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, and Vice-Dean at the Faculty of Medicine, Lund University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH